ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
Yf-Vax 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 678만 달러에서 2026년에는 732만 달러에 이르고, CAGR 7.9%로 성장할 전망입니다. 지난 몇 년간의 성장 요인으로는 황열병 유행 지역, 국제 여행 요건, 장기적인 면역 효과 입증, 정부의 예방접종 의무화, 공중보건 정책 등을 꼽을 수 있습니다.
Yf-Vax 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 981만 달러에 이르고, CAGR은 7.6%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 세계 여행 증가, 기후 변화에 따른 모기 확산, 예방접종 대상 확대, 발병 대책 자금 증가, 공중보건 감시체계 강화 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 여행용 백신 수요 증가, 정부 주도의 예방접종 프로그램, 약독성 생백신의 지속적인 사용, 풍토병 예방에 대한 집중, 발병 대비를 위한 비축 등을 들 수 있습니다.
매개체 질환에 대한 인식이 높아짐에 따라 향후 몇 년간 YF-Vax 시장의 성장을 견인할 것으로 예측됩니다. 매개체 질환은 바이러스, 세균, 기생충을 보유한 모기, 진드기, 벼룩 등 감염된 절지동물의 물림을 통해 사람이나 동물에게 전염되는 감염병으로 말라리아, 뎅기열, 라임병 등의 질병을 유발할 수 있습니다. 매개체 감염병 증가 추세는 기후 변화, 도시화, 국제 이동 증가, 모기 개체수 증가로 인한 모기 개체수 증가로 인해 보고되는 발생 건수가 증가하고 있습니다. YF-Vax는 매개 감염병인 황열병에 대해 면역체계를 자극하여 항체를 생성하고, 감염된 모기에 의해 매개되는 바이러스에 대한 장기적인 면역력을 확보하여 효과적인 보호 효과를 제공합니다. 예를 들어, 2024년 3월 국제수역사무국이 발표한 자료에 따르면, 2023년부터 2024년 3월까지 28개국에서 2,422건의 매개체 질병 발생이 보고되었으며, 유럽에서만 697건이 발생하였습니다. 따라서 매개체 질환에 대한 인식이 높아지면서 YF-Vax 시장의 성장을 뒷받침하고 있습니다.
국제 여행 수요 증가도 YF-Vax 시장의 성장을 가속할 것으로 예측됩니다. 국제여행이란 관광, 비즈니스, 교육, 가족 방문 등의 목적으로 국경을 넘는 것을 말합니다. 전 세계적으로 가처분 소득이 증가함에 따라 더 많은 사람들이 여가 목적으로 해외여행을 할 수 있게 되었고, 황열병 유행지역을 방문하는 여행객의 예방접종 필요성이 증가하고 있습니다. 여행 관련 백신 접종 요건은 백신 접종을 더욱 촉진하고 전염병으로부터의 보호를 보장하며 전 세계 공중 보건 조치를 지원합니다. 예를 들어, 2025년 6월 FREETOUR.com이 발표한 데이터에 따르면, 영국 거주자의 2024년 해외여행 횟수는 9,000만 회를 넘어섰고, 2025년에는 9,200만 회를 넘어설 것으로 예측됩니다. 동시에 영국을 방문하는 해외 방문객 수는 4,340만 명에 달할 것으로 예측됩니다. 이처럼 국제 여행 수요 증가는 YF-Vax 시장의 성장에 기여하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 한국 시장
제17장 서유럽 시장
제18장 영국 시장
제19장 독일 시장
제20장 프랑스 시장
제21장 동유럽 시장
제22장 북미 시장
제23장 미국 시장
제24장 캐나다 시장
제25장 남미 시장
제26장 중동 시장
제27장 아프리카 시장
제28장 시장 규제 상황과 투자환경
제29장 경쟁 구도와 기업 개요
제30장 세계 시장 경쟁 벤치마킹과 대시보드
제31장 주요 인수합병(M&A)
제32장 시장 잠재력이 높은 국가, 부문, 전략
제33장 부록
LSH
영문 목차
영문목차
YF-Vax is a live-attenuated vaccine designed to provide long-term protection against yellow fever, a potentially serious viral disease transmitted by infected mosquitoes. It is commonly recommended for travelers and residents in endemic regions.
The main forms of YF-Vax are live attenuated vaccines and fractional dose vaccines. Live attenuated vaccines contain live, but weakened, forms of the virus that cause the disease. Yellow fever can be transmitted through sylvatic, intermediate, and urban cycles. YF-Vax is distributed through hospitals, retail pharmacies, and government health programs, and is used by adults, geriatric populations, and pediatric patients.
Tariffs have affected the yf-vax market by increasing costs of vaccine manufacturing materials and cold chain distribution systems. These impacts are most visible in government health programs across africa, latin america, and parts of asia pacific. Higher import duties have influenced procurement budgets for large scale immunization campaigns. Logistics timelines have also been impacted by cross border regulatory requirements. However, tariffs are encouraging localized vaccine production and regional supply self sufficiency.
The yf-vax market research report is one of a series of new reports from The Business Research Company that provides yf-vax market statistics, including yf-vax industry global market size, regional shares, competitors with a yf-vax market share, detailed yf-vax market segments, market trends and opportunities, and any further data you may need to thrive in the yf-vax industry. This yf-vax market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The yf-vax market size has grown strongly in recent years. It will grow from $6.78 million in 2025 to $7.32 million in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to yellow fever endemic regions, international travel requirements, proven long term immunity, government vaccination mandates, public health initiatives.
The yf-vax market size is expected to see strong growth in the next few years. It will grow to $9.81 million in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing global travel, climate driven mosquito spread, expanded immunization coverage, rising outbreak preparedness funding, public health surveillance growth. Major trends in the forecast period include rising demand for travel vaccination, government led immunization programs, continued use of live attenuated vaccines, focus on endemic disease prevention, stockpiling for outbreak preparedness.
The growing awareness of vector-borne diseases is expected to drive the growth of the YF-Vax market in the coming years. Vector-borne diseases are infectious illnesses transmitted to humans and animals through the bites of infected arthropods, such as mosquitoes, ticks, and fleas, carrying viruses, bacteria, or parasites, which can cause diseases like malaria, dengue, and Lyme disease. The increasing prevalence of vector-borne diseases is attributed to climate change, urbanization, global travel, and expanding mosquito populations, resulting in more reported outbreaks. YF-Vax provides effective protection against yellow fever, a vector-borne disease, by stimulating the immune system to produce antibodies and ensuring long-lasting immunity against the virus transmitted by infected mosquitoes. For example, in March 2024, the World Organization for Animal Health reported 2,422 vector-borne disease outbreaks across 28 countries from 2023 to March 2024, with Europe alone accounting for 697 outbreaks. Therefore, increasing awareness of vector-borne diseases is supporting growth in the YF-Vax market.
The rising demand for international travel is also expected to propel the YF-Vax market forward. International travel involves crossing national borders for purposes such as tourism, business, education, or visiting family. The increase in global disposable incomes has enabled more people to travel abroad for leisure, boosting the need for preventive vaccination among travelers visiting yellow fever-endemic regions. Travel-related vaccine requirements further drive uptake, ensuring protection against outbreaks and supporting public health efforts worldwide. For instance, in June 2025, FREETOUR.com reported that UK residents made over 90 million outbound trips in 2024 and are projected to make over 92 million outbound trips while receiving 43.4 million international visitors in 2025. Consequently, the rising demand for international travel is contributing to the growth of the YF-Vax market.
Rising healthcare spending is also expected to support the growth of the YF-Vax market. Healthcare expenditure, driven by aging populations, technological advancements, the increasing prevalence of chronic diseases, and greater demand for healthcare services, underpins vaccination efforts. YF-Vax reduces healthcare costs by preventing severe infections, hospitalizations, and outbreak management expenses. For example, in May 2024, the UK's Office for National Statistics reported that healthcare spending increased by 5.6% between 2022 and 2023, compared with 0.9% growth in 2022, reaching approximately $317.63 billion (£292 billion) in 2023. Therefore, rising healthcare expenditure is driving growth in the YF-Vax market.
Major companies operating in the yf-vax market are Sanofi S.A.
North America was the largest region in the yf-vax market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yf-vax market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the yf-vax market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
The yf-vax market consists of sales of vaccine syringes, pre-filled injection devices, and immunization kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Yf-Vax Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses yf-vax market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for yf-vax ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The yf-vax market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Vaccine Type: Live Attenuated Vaccines; Fractional Dose Vaccine
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
6. Yf-Vax Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Yf-Vax Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Yf-Vax PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Yf-Vax Market Size, Comparisons And Growth Rate Analysis
7.3. Global Yf-Vax Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Yf-Vax Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Yf-Vax Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Yf-Vax Market Segmentation
9.1. Global Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Live Attenuated Vaccines, Fractional Dose Vaccine
9.2. Global Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.3. Global Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Retail Pharmacies, Government Health Programs
9.4. Global Yf-Vax Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Adult, Geriatric, Pediatric
10. Yf-Vax Market Regional And Country Analysis
10.1. Global Yf-Vax Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Yf-Vax Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Yf-Vax Market
11.1. Asia-Pacific Yf-Vax Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Yf-Vax Market, Segmentation By Vaccine Type, Segmentation By Transmission Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Yf-Vax Market
12.1. China Yf-Vax Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Yf-Vax Market, Segmentation By Vaccine Type, Segmentation By Transmission Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Yf-Vax Market
13.1. India Yf-Vax Market, Segmentation By Vaccine Type, Segmentation By Transmission Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Yf-Vax Market
14.1. Japan Yf-Vax Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Yf-Vax Market, Segmentation By Vaccine Type, Segmentation By Transmission Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Yf-Vax Market
15.1. Australia Yf-Vax Market, Segmentation By Vaccine Type, Segmentation By Transmission Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. South Korea Yf-Vax Market
16.1. South Korea Yf-Vax Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
16.2. South Korea Yf-Vax Market, Segmentation By Vaccine Type, Segmentation By Transmission Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. Western Europe Yf-Vax Market
17.1. Western Europe Yf-Vax Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. Western Europe Yf-Vax Market, Segmentation By Vaccine Type, Segmentation By Transmission Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. UK Yf-Vax Market
18.1. UK Yf-Vax Market, Segmentation By Vaccine Type, Segmentation By Transmission Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. Germany Yf-Vax Market
19.1. Germany Yf-Vax Market, Segmentation By Vaccine Type, Segmentation By Transmission Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. France Yf-Vax Market
20.1. France Yf-Vax Market, Segmentation By Vaccine Type, Segmentation By Transmission Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. Eastern Europe Yf-Vax Market
21.1. Eastern Europe Yf-Vax Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
21.2. Eastern Europe Yf-Vax Market, Segmentation By Vaccine Type, Segmentation By Transmission Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. North America Yf-Vax Market
22.1. North America Yf-Vax Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
22.2. North America Yf-Vax Market, Segmentation By Vaccine Type, Segmentation By Transmission Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. USA Yf-Vax Market
23.1. USA Yf-Vax Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
23.2. USA Yf-Vax Market, Segmentation By Vaccine Type, Segmentation By Transmission Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Canada Yf-Vax Market
24.1. Canada Yf-Vax Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
24.2. Canada Yf-Vax Market, Segmentation By Vaccine Type, Segmentation By Transmission Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. South America Yf-Vax Market
25.1. South America Yf-Vax Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
25.2. South America Yf-Vax Market, Segmentation By Vaccine Type, Segmentation By Transmission Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Middle East Yf-Vax Market
26.1. Middle East Yf-Vax Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Middle East Yf-Vax Market, Segmentation By Vaccine Type, Segmentation By Transmission Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Africa Yf-Vax Market
27.1. Africa Yf-Vax Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
27.2. Africa Yf-Vax Market, Segmentation By Vaccine Type, Segmentation By Transmission Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. Yf-Vax Market Regulatory and Investment Landscape
29. Yf-Vax Market Competitive Landscape And Company Profiles
29.1. Yf-Vax Market Competitive Landscape And Market Share 2024
29.1.1. Top 10 Companies (Ranked by revenue/share)
29.2. Yf-Vax Market - Company Scoring Matrix
29.2.1. Market Revenues
29.2.2. Product Innovation Score
29.2.3. Brand Recognition
29.3. Yf-Vax Market Company Profiles
29.3.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
30. Global Yf-Vax Market Competitive Benchmarking And Dashboard
31. Key Mergers And Acquisitions In The Yf-Vax Market
32. Yf-Vax Market High Potential Countries, Segments and Strategies
32.1 Yf-Vax Market In 2030 - Countries Offering Most New Opportunities
32.2 Yf-Vax Market In 2030 - Segments Offering Most New Opportunities
